Evaluation and Management of Fatigue with Testosterone 346 ng/dL
Your testosterone level of 346 ng/dL does not meet diagnostic criteria for hypogonadism, and testosterone therapy is not indicated for fatigue alone—even if biochemical hypogonadism were confirmed, testosterone produces little to no meaningful improvement in energy or vitality.
Why Testosterone Therapy Is Not Appropriate
Diagnostic Threshold Not Met
- Hypogonadism requires two separate fasting morning (8–10 AM) total testosterone measurements both < 300 ng/dL; a single value of 346 ng/dL is above this threshold and does not confirm the diagnosis. 1, 2, 3
- Even if you had a second morning value < 300 ng/dL, diagnosis also requires specific symptoms—primarily diminished libido and erectile dysfunction—not fatigue. 1, 4
Fatigue Does Not Respond to Testosterone
- High-quality evidence demonstrates that testosterone therapy produces negligible improvement in energy and fatigue (standardized mean difference 0.17), well below the threshold for clinical significance. 1
- Fatigue, low energy, depressed mood, poor concentration, and reduced physical strength show minimal correlation with serum testosterone levels and do not improve reliably with replacement therapy. 1
- Even in men with confirmed biochemical hypogonadism (testosterone < 300 ng/dL on two occasions), testosterone therapy has little to no effect on physical functioning, energy, vitality, depressive symptoms, or cognition. 1, 4
What Testosterone Does Improve
- The only proven benefit is a small but statistically significant improvement in sexual function and libido (standardized mean difference ≈ 0.35) in men with both low testosterone and sexual symptoms. 1, 4
- Quality-of-life improvements are modest and confined to sexual function domains; there is no meaningful enhancement of general well-being. 1
Recommended Initial Evaluation for Fatigue
Rule Out Common Reversible Causes
- Screen for hypothyroidism (TSH), anemia (CBC with differential), vitamin D deficiency (25-OH vitamin D), diabetes (fasting glucose, HbA1c), and depression (PHQ-9 or clinical assessment). 1
- Evaluate for sleep disorders, particularly obstructive sleep apnea if risk factors are present (obesity, snoring, witnessed apneas). 1
- Assess for metabolic syndrome and cardiovascular risk factors (lipid profile, blood pressure, waist circumference). 1
Consider Obesity-Related Factors
- If you are obese, weight loss through a hypocaloric diet (500–750 kcal/day deficit) and structured exercise (≥ 150 min/week moderate-intensity aerobic activity plus resistance training 2–3 times/week) can improve testosterone levels modestly and may address fatigue through metabolic pathways. 1, 2
- A 5–10% weight loss can significantly increase endogenous testosterone production in obese men with secondary hypogonadism. 1
If You Still Want Testosterone Testing
Confirm Whether True Hypogonadism Exists
- Repeat morning total testosterone (8–10 AM) on at least one additional occasion to see if both values are < 300 ng/dL. 1, 2, 3
- If both values are < 300 ng/dL, measure free testosterone by equilibrium dialysis (or calculate free androgen index = total testosterone ÷ SHBG × 100) and obtain LH, FSH, and SHBG to distinguish primary from secondary hypogonadism. 1, 2
- If LH/FSH are low or low-normal, screen for reversible causes: prolactin (to exclude prolactinoma), iron saturation (to exclude hemochromatosis), and consider pituitary MRI if testosterone < 150 ng/dL with LH/FSH < 1.5 IU/L. 1, 2
Even If Hypogonadism Is Confirmed
- Testosterone therapy should be initiated only if you have diminished libido or erectile dysfunction as primary symptoms—not fatigue. 1, 4
- Set realistic expectations: you can anticipate modest improvements in sexual function only, with no expected gains in energy, mood, or cognitive performance. 1
Critical Pitfalls to Avoid
- Do not diagnose hypogonadism on a single testosterone measurement or on symptoms alone; two morning values < 300 ng/dL plus specific sexual symptoms are required. 1, 2, 3
- Do not prescribe testosterone for fatigue, weight loss, general energy enhancement, or athletic performance—these are not evidence-based indications. 1
- Approximately 20–30% of men receiving testosterone in the United States do not have documented low testosterone levels before treatment initiation, a practice pattern that violates evidence-based guidelines. 1
- Never assume that age-related decline in testosterone is a disease requiring treatment; the FDA mandates that testosterone products be labeled for use only in men with low testosterone due to known medical causes, not for age-related decline. 1
Summary Algorithm
- Address reversible causes of fatigue first: thyroid, anemia, vitamin D, diabetes, sleep apnea, depression. 1
- If obese, prioritize weight loss and exercise before considering any hormonal evaluation. 1, 2
- If you have sexual symptoms (low libido, erectile dysfunction), repeat morning testosterone to confirm both values < 300 ng/dL, then complete hypogonadism workup (LH, FSH, free testosterone, SHBG). 1, 2, 4
- If both testosterone values remain > 300 ng/dL, testosterone therapy is not indicated regardless of symptoms. 1
- If confirmed hypogonadism with sexual symptoms, consider testosterone therapy with realistic expectations (small improvement in sexual function only, no benefit for energy). 1, 4